Oragenics Appoints Dr. William “Frank” Peacock as Chief Clinical Officer for Conducting Phase II Clinical Trial
Position
Chief Clinical Officer
Company
Oragenics
SarasotaBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Oragenics, Inc. has appointed Dr. William “Frank” Peacock as its Chief Clinical Officer to oversee the anticipated Phase II clinical trial for treating concussion in the Emergency Department (ED), with the drug candidate ONP-002.
Quick answer
Oragenics Appoints Dr. William “Frank” Peacock as Chief Clinical Officer for Conducting Phase II Clinical Trial (May 22, 2024). Oragenics is based in Sarasota, Florida, United States.
- Who is the new Chief Clinical Officer at Oragenics?
- Oragenics named Frank Peacock Chief Clinical Officer, announced May 22, 2024.
- What did Oragenics announce on May 22, 2024?
- Oragenics, Inc. has appointed Dr. William “Frank” Peacock as its Chief Clinical Officer to oversee the anticipated Phase II clinical trial for treating concussion in the Emergency Department (ED), with the drug candidate ONP-002.
- What does Oragenics do?
- Oragenics, Inc. is a biopharmaceutical company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders.
- Where is Oragenics based?
- Oragenics is based in Sarasota, Florida, United States.
- Which similar companies made leadership changes around the same time?
- Nurix Therapeutics (May 28, 2024), Tarsier Pharma (May 28, 2024), Alkeus Pharmaceuticals (May 29, 2024) and Crinetics Pharmaceuticals (May 30, 2024) also announced leadership changes within 45 days of Oragenics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Nurix Therapeutics Appoints Paula G. O’Connor as Chief Medical Officer and Pasit Phiasivongsa as Chief Technical Officer (May 28, 2024)
- Tarsier Pharma Appoints Emilee Fulcher as Vice President of Clinical Affairs (May 28, 2024)
- Alkeus Pharmaceuticals Appoints Eric L. Trachtenberg as Chief Legal Officer (May 29, 2024)
- Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D. as Senior Vice President of Medical Affairs (May 30, 2024)
- Contineum Therapeutics Appoints John Healy as General Counsel & Corporate Secretary (June 3, 2024)
- YS Biopharma Appoints Dave Chenn as Interim CEO and Hui Shao as Co-CEO and CBO (May 7, 2024)
Who to call at Oragenics, and when
A new leader at Oragenics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Oragenics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Oragenics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Oragenics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Oragenics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Oragenics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.